VVOS's Insider Trades

Healthcare

Medical Devices

DATE

INSIDER

COMPANY

OWNED SHARES

SHARES TRADED

PRICE

NET TOTAL

BUY

20 Jun 2023

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer

Vivos Therapeutics, Inc.

(VVOS)

86,521+19%

14,000

$0.53

$7,420.00

BUY

15 Jun 2023

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer

Vivos Therapeutics, Inc.

(VVOS)

67,521+28%

15,021

$0.54

$8,060.50

BUY

14 Jun 2023

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer

Vivos Therapeutics, Inc.

(VVOS)

57,500+21%

10,000

$0.49

$4,900.00

BUY

23 Dec 2022

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer, 10% Owner

Vivos Therapeutics, Inc.

(VVOS)

47,500+72%

20,000

$0.50

$10,000.00

BUY

31 May 2022

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer, 10% Owner

Vivos Therapeutics, Inc.

(VVOS)

27,500+77%

12,000

$1.96

$23,560.00

BUY

21 Sep 2021

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer

Vivos Therapeutics, Inc.

(VVOS)

15,500+47%

5,000

$4.31

$21,550.00

BUY

17 Aug 2021

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer

Vivos Therapeutics, Inc.

(VVOS)

10,500+90%

5,000

$3.00

$15,000.00

BUY

25 May 2021

Amman Bradford K.

Chief Financial Officer, Officer

Vivos Therapeutics, Inc.

(VVOS)

2,000+100%

1,000

$5.29

$5,290.00

BUY

25 May 2021

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer

Vivos Therapeutics, Inc.

(VVOS)

5,500+266%

4,000

$5.38

$21,520.00

BUY

24 Dec 2020

Amman Bradford K.

Chief Financial Officer, Officer

Vivos Therapeutics, Inc.

(VVOS)

1,000+100%

1,000

$7.38

$7,380.00

BUY

23 Dec 2020

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer, 10% Owner

Vivos Therapeutics, Inc.

(VVOS)

1,500+200%

1,000

$7.27

$7,266.90

BUY

11 Dec 2020

Huntsman Ronald Kirk

Chief Executive Officer, Director, Officer, 10% Owner

Vivos Therapeutics, Inc.

(VVOS)

500+100%

500

$8.50

$4,250.00

Home